Veri Medtech Holdings Inc.
VRHI
$1.65
$0.031.85%
OTC PK
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 12.15% | -15.11% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 12.15% | -15.11% | |||
| Cost of Revenue | 3.79% | -6.90% | |||
| Gross Profit | 15.02% | -17.62% | |||
| SG&A Expenses | -23.13% | 4.17% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -18.40% | 2.04% | |||
| Operating Income | 85.25% | -82.94% | |||
| Income Before Tax | 84.19% | -80.82% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 80.30% | -80.82% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 80.30% | -80.82% | |||
| EBIT | 85.25% | -82.94% | |||
| EBITDA | 85.42% | -83.23% | |||
| EPS Basic | 80.31% | -80.78% | |||
| Normalized Basic EPS | 84.23% | -81.14% | |||
| EPS Diluted | 90.50% | -274.73% | |||
| Normalized Diluted EPS | 84.23% | -81.14% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||